CLOS
LLY icon

Compagnie Lombard Odier SCmA’s Eli Lilly LLY Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245M Buy
265,844
+9,044
+4% +$9.17M 3.01% 8
2025
Q4 		$276M Sell
256,800
-7,557
-3% -$7.23M 3% 8
2025
Q3 		$202M Buy
264,357
+27,425
+12% +$20.4M 2.23% 12
2025
Q2 		$185M Buy
236,932
+16,071
+7% +$12.5M 2.44% 11
2025
Q1 		$182M Buy
220,861
+93,212
+73% +$77.6M 2.24% 12
2024
Q4 		$98.5M Buy
127,649
+56,285
+79% +$46.6M 1.45% 16
2024
Q3 		$63.2M Buy
71,364
+5,498
+8% +$4.94M 0.98% 29
2024
Q2 		$59.6M Buy
65,866
+10,031
+18% +$8.02M 1.01% 25
2024
Q1 		$43.4M Buy
55,835
+14,574
+35% +$10.4M 0.77% 36
2023
Q4 		$24.1M Buy
41,261
+23,883
+137% +$13.9M 0.45% 54
2023
Q3 		$9.33M Buy
17,378
+11,134
+178% +$5.74M 0.22% 70
2023
Q2 		$2.93M Buy
6,244
+2,958
+90% +$1.24M 0.08% 98
2023
Q1 		$1.13M Buy
3,286
+1,611
+96% +$543K 0.03% 155
2022
Q4 		$612K Buy
1,675
+795
+90% +$282K 0.02% 186
2022
Q3 		$284K Sell
880
-496
-36% -$157K 0.01% 260
2022
Q2 		$446K Buy
1,376
+360
+35% +$108K 0.01% 211
2022
Q1 		$291K Sell
1,016
-189
-16% -$48.6K 0.01% 267
2021
Q4 		$333K Buy
1,205
+300
+33% +$76.1K 0.01% 294
2021
Q3 		$209K Hold
905
– – ﹤0.01% 353
2021
Q2 		$207K Hold
905
– – ﹤0.01% 340
2021
Q1 		$169K Sell
905
-850
-48% -$166K ﹤0.01% 403
2020
Q4 		$296K Buy
+1,755
New +$262K 0.01% 287
2019
Q4 		– Sell
-451
Closed -$50K – 544
2019
Q3 		$50K Buy
+451
New +$50.2K ﹤0.01% 359
2019
Q2 		– Sell
-800
Closed -$104K – 568
2019
Q1 		$104K Hold
800
– – ﹤0.01% 343
2018
Q4 		$93K Hold
800
– – ﹤0.01% 336
2018
Q3 		$86K Buy
800
+390
+95% +$39K ﹤0.01% 368
2018
Q2 		$35K Hold
410
– – ﹤0.01% 473
2018
Q1 		$32K Sell
410
-410
-50% -$33K ﹤0.01% 494
2017
Q4 		$70K Sell
820
-991
-55% -$84.3K ﹤0.01% 513
2017
Q3 		$154K Hold
1,811
– – 0.01% 394
2017
Q2 		$149K Buy
1,811
+816
+82% +$66.6K 0.01% 379
2017
Q1 		$84K Sell
995
-11,717
-92% -$938K ﹤0.01% 466
2016
Q4 		$935K Buy
12,712
+8,731
+219% +$650K 0.03% 261
2016
Q3 		$319K Buy
3,981
+375
+10% +$30K 0.01% 404
2016
Q2 		$284K Sell
3,606
-7,224
-67% -$544K 0.01% 431
2016
Q1 		$780K Buy
10,830
+450
+4% +$34K 0.02% 289
2015
Q4 		$875K Buy
10,380
+150
+1% +$12.4K 0.03% 250
2015
Q3 		$857K Buy
10,230
+67
+0.7% +$5.66K 0.03% 218
2015
Q2 		$848K Sell
10,163
-761
-7% -$58K 0.03% 237
2015
Q1 		$794K Buy
10,924
+7,930
+265% +$565K 0.03% 252
2014
Q4 		$207K Sell
2,994
-11,576
-79% -$781K 0.01% 410
2014
Q3 		$944K Sell
14,570
-33
-0.2% -$2.09K 0.04% 192
2014
Q2 		$908K Sell
14,603
-5,082
-26% -$303K 0.04% 209
2014
Q1 		$1.16M Buy
19,685
+3,194
+19% +$178K 0.05% 177
2013
Q4 		$842K Buy
+16,491
New +$826K 0.04% 233

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Compagnie Lombard Odier SCmA's LLY Position: Q1 2026 in Review

Compagnie Lombard Odier SCmA increased its Eli Lilly (LLY) stake by 3.5% in Q1 2026, buying an estimated $9.17M and bringing the position to 265,844 shares worth $245M. The position accounts for 3.01% of the portfolio, ranked #8.

Compagnie Lombard Odier SCmA first reported a position in LLY in Q4 2013 and has held it in 45 quarters since. The position peaked at $276M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Compagnie Lombard Odier SCmA held 265,844 shares of Eli Lilly worth $245M as of Q1 2026.
  • Compagnie Lombard Odier SCmA bought 9,044 Eli Lilly shares in Q1 2026, an estimated $9.17M.
  • Eli Lilly made up 3.01% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #8 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Eli Lilly in Q4 2013 and has held it in 45 quarters since.
  • Compagnie Lombard Odier SCmA's Eli Lilly position peaked at $276M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.